The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vinorelbine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Vinorelbine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Vinorelbine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Breast Cancer accounting for % of the Vinorelbine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Vinorelbine include Pierre Fabre Pharmaceuticals, Inc., TEVA Pharms, Hospira, Inc., West-Ward Pharmaceuticals Corp., and Fresenius Kabi, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Vinorelbine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injection
Market segment by Application can be divided into
Breast Cancer
Non-small Cell Lung Cancer
Other
The key market players for global Vinorelbine market are listed below:
Pierre Fabre Pharmaceuticals, Inc.
TEVA Pharms
Hospira, Inc.
West-Ward Pharmaceuticals Corp.
Fresenius Kabi
EBEWE Pharma (Sandoz A Novartis Division)
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Mylan
Dr. Reddy's Laboratories
Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
Nanjing Cuccess Pharmaceutical Co., Ltd
Qilu Pharmaceutical (Hainan) Co., Ltd.
Sinopharm A-Think Pharmaceutical Co., Ltd.
Beijing SL Pharm
Shenzhen Main Luck Pharmaceuticals Inc.
Shanxi Powerdone Pharmaceutics Co., Ltd.
Luoxin Pharmaceutical Group Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vinorelbine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vinorelbine, with price, sales, revenue and global market share of Vinorelbine from 2019 to 2022.
Chapter 3, the Vinorelbine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vinorelbine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Vinorelbine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Vinorelbine.
Chapter 13, 14, and 15, to describe Vinorelbine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Vinorelbine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Vinorelbine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Breast Cancer accounting for % of the Vinorelbine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Vinorelbine include Pierre Fabre Pharmaceuticals, Inc., TEVA Pharms, Hospira, Inc., West-Ward Pharmaceuticals Corp., and Fresenius Kabi, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Vinorelbine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injection
Market segment by Application can be divided into
Breast Cancer
Non-small Cell Lung Cancer
Other
The key market players for global Vinorelbine market are listed below:
Pierre Fabre Pharmaceuticals, Inc.
TEVA Pharms
Hospira, Inc.
West-Ward Pharmaceuticals Corp.
Fresenius Kabi
EBEWE Pharma (Sandoz A Novartis Division)
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Mylan
Dr. Reddy's Laboratories
Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
Nanjing Cuccess Pharmaceutical Co., Ltd
Qilu Pharmaceutical (Hainan) Co., Ltd.
Sinopharm A-Think Pharmaceutical Co., Ltd.
Beijing SL Pharm
Shenzhen Main Luck Pharmaceuticals Inc.
Shanxi Powerdone Pharmaceutics Co., Ltd.
Luoxin Pharmaceutical Group Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vinorelbine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vinorelbine, with price, sales, revenue and global market share of Vinorelbine from 2019 to 2022.
Chapter 3, the Vinorelbine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vinorelbine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Vinorelbine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Vinorelbine.
Chapter 13, 14, and 15, to describe Vinorelbine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Vinorelbine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vinorelbine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oral
1.2.3 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Vinorelbine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Breast Cancer
1.3.3 Non-small Cell Lung Cancer
1.3.4 Other
1.4 Global Vinorelbine Market Size & Forecast
1.4.1 Global Vinorelbine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Vinorelbine Sales in Volume (2017-2028)
1.4.3 Global Vinorelbine Price (2017-2028)
1.5 Global Vinorelbine Production Capacity Analysis
1.5.1 Global Vinorelbine Total Production Capacity (2017-2028)
1.5.2 Global Vinorelbine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vinorelbine Market Drivers
1.6.2 Vinorelbine Market Restraints
1.6.3 Vinorelbine Trends Analysis
2 Manufacturers Profiles
2.1 Pierre Fabre Pharmaceuticals, Inc.
2.1.1 Pierre Fabre Pharmaceuticals, Inc. Details
2.1.2 Pierre Fabre Pharmaceuticals, Inc. Major Business
2.1.3 Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Product and Services
2.1.4 Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 TEVA Pharms
2.2.1 TEVA Pharms Details
2.2.2 TEVA Pharms Major Business
2.2.3 TEVA Pharms Vinorelbine Product and Services
2.2.4 TEVA Pharms Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Hospira, Inc.
2.3.1 Hospira, Inc. Details
2.3.2 Hospira, Inc. Major Business
2.3.3 Hospira, Inc. Vinorelbine Product and Services
2.3.4 Hospira, Inc. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 West-Ward Pharmaceuticals Corp.
2.4.1 West-Ward Pharmaceuticals Corp. Details
2.4.2 West-Ward Pharmaceuticals Corp. Major Business
2.4.3 West-Ward Pharmaceuticals Corp. Vinorelbine Product and Services
2.4.4 West-Ward Pharmaceuticals Corp. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Fresenius Kabi
2.5.1 Fresenius Kabi Details
2.5.2 Fresenius Kabi Major Business
2.5.3 Fresenius Kabi Vinorelbine Product and Services
2.5.4 Fresenius Kabi Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 EBEWE Pharma (Sandoz A Novartis Division)
2.6.1 EBEWE Pharma (Sandoz A Novartis Division) Details
2.6.2 EBEWE Pharma (Sandoz A Novartis Division) Major Business
2.6.3 EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Product and Services
2.6.4 EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
2.7.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Details
2.7.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
2.7.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Product and Services
2.7.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Vinorelbine Product and Services
2.8.4 Mylan Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Dr. Reddy's Laboratories
2.9.1 Dr. Reddy's Laboratories Details
2.9.2 Dr. Reddy's Laboratories Major Business
2.9.3 Dr. Reddy's Laboratories Vinorelbine Product and Services
2.9.4 Dr. Reddy's Laboratories Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
2.10.1 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Details
2.10.2 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Major Business
2.10.3 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Product and Services
2.10.4 Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Nanjing Cuccess Pharmaceutical Co., Ltd
2.11.1 Nanjing Cuccess Pharmaceutical Co., Ltd Details
2.11.2 Nanjing Cuccess Pharmaceutical Co., Ltd Major Business
2.11.3 Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Product and Services
2.11.4 Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Qilu Pharmaceutical (Hainan) Co., Ltd.
2.12.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Details
2.12.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
2.12.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Product and Services
2.12.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Sinopharm A-Think Pharmaceutical Co., Ltd.
2.13.1 Sinopharm A-Think Pharmaceutical Co., Ltd. Details
2.13.2 Sinopharm A-Think Pharmaceutical Co., Ltd. Major Business
2.13.3 Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Product and Services
2.13.4 Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Beijing SL Pharm
2.14.1 Beijing SL Pharm Details
2.14.2 Beijing SL Pharm Major Business
2.14.3 Beijing SL Pharm Vinorelbine Product and Services
2.14.4 Beijing SL Pharm Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Shenzhen Main Luck Pharmaceuticals Inc.
2.15.1 Shenzhen Main Luck Pharmaceuticals Inc. Details
2.15.2 Shenzhen Main Luck Pharmaceuticals Inc. Major Business
2.15.3 Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Product and Services
2.15.4 Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Shanxi Powerdone Pharmaceutics Co., Ltd.
2.16.1 Shanxi Powerdone Pharmaceutics Co., Ltd. Details
2.16.2 Shanxi Powerdone Pharmaceutics Co., Ltd. Major Business
2.16.3 Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Product and Services
2.16.4 Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Luoxin Pharmaceutical Group Co., Ltd.
2.17.1 Luoxin Pharmaceutical Group Co., Ltd. Details
2.17.2 Luoxin Pharmaceutical Group Co., Ltd. Major Business
2.17.3 Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Product and Services
2.17.4 Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Vinorelbine Breakdown Data by Manufacturer
3.1 Global Vinorelbine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Vinorelbine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Vinorelbine
3.4 Market Concentration Rate
3.4.1 Top 3 Vinorelbine Manufacturer Market Share in 2021
3.4.2 Top 6 Vinorelbine Manufacturer Market Share in 2021
3.5 Global Vinorelbine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Vinorelbine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Vinorelbine Market Size by Region
4.1.1 Global Vinorelbine Sales in Volume by Region (2017-2028)
4.1.2 Global Vinorelbine Revenue by Region (2017-2028)
4.2 North America Vinorelbine Revenue (2017-2028)
4.3 Europe Vinorelbine Revenue (2017-2028)
4.4 Asia-Pacific Vinorelbine Revenue (2017-2028)
4.5 South America Vinorelbine Revenue (2017-2028)
4.6 Middle East and Africa Vinorelbine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Vinorelbine Sales in Volume by Type (2017-2028)
5.2 Global Vinorelbine Revenue by Type (2017-2028)
5.3 Global Vinorelbine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Vinorelbine Sales in Volume by Application (2017-2028)
6.2 Global Vinorelbine Revenue by Application (2017-2028)
6.3 Global Vinorelbine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Vinorelbine Sales by Type (2017-2028)
7.2 North America Vinorelbine Sales by Application (2017-2028)
7.3 North America Vinorelbine Market Size by Country
7.3.1 North America Vinorelbine Sales in Volume by Country (2017-2028)
7.3.2 North America Vinorelbine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Vinorelbine Sales by Type (2017-2028)
8.2 Europe Vinorelbine Sales by Application (2017-2028)
8.3 Europe Vinorelbine Market Size by Country
8.3.1 Europe Vinorelbine Sales in Volume by Country (2017-2028)
8.3.2 Europe Vinorelbine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Vinorelbine Sales by Type (2017-2028)
9.2 Asia-Pacific Vinorelbine Sales by Application (2017-2028)
9.3 Asia-Pacific Vinorelbine Market Size by Region
9.3.1 Asia-Pacific Vinorelbine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Vinorelbine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Vinorelbine Sales by Type (2017-2028)
10.2 South America Vinorelbine Sales by Application (2017-2028)
10.3 South America Vinorelbine Market Size by Country
10.3.1 South America Vinorelbine Sales in Volume by Country (2017-2028)
10.3.2 South America Vinorelbine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Vinorelbine Sales by Type (2017-2028)
11.2 Middle East & Africa Vinorelbine Sales by Application (2017-2028)
11.3 Middle East & Africa Vinorelbine Market Size by Country
11.3.1 Middle East & Africa Vinorelbine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Vinorelbine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Vinorelbine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Vinorelbine
12.3 Vinorelbine Production Process
12.4 Vinorelbine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Vinorelbine Typical Distributors
13.3 Vinorelbine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Vinorelbine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Vinorelbine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pierre Fabre Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pierre Fabre Pharmaceuticals, Inc. Major Business
Table 5. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Product and Services
Table 6. Pierre Fabre Pharmaceuticals, Inc. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. TEVA Pharms Basic Information, Manufacturing Base and Competitors
Table 8. TEVA Pharms Major Business
Table 9. TEVA Pharms Vinorelbine Product and Services
Table 10. TEVA Pharms Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Hospira, Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Hospira, Inc. Major Business
Table 13. Hospira, Inc. Vinorelbine Product and Services
Table 14. Hospira, Inc. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. West-Ward Pharmaceuticals Corp. Basic Information, Manufacturing Base and Competitors
Table 16. West-Ward Pharmaceuticals Corp. Major Business
Table 17. West-Ward Pharmaceuticals Corp. Vinorelbine Product and Services
Table 18. West-Ward Pharmaceuticals Corp. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 20. Fresenius Kabi Major Business
Table 21. Fresenius Kabi Vinorelbine Product and Services
Table 22. Fresenius Kabi Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. EBEWE Pharma (Sandoz A Novartis Division) Basic Information, Manufacturing Base and Competitors
Table 24. EBEWE Pharma (Sandoz A Novartis Division) Major Business
Table 25. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Product and Services
Table 26. EBEWE Pharma (Sandoz A Novartis Division) Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 28. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
Table 29. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Product and Services
Table 30. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Major Business
Table 33. Mylan Vinorelbine Product and Services
Table 34. Mylan Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 36. Dr. Reddy's Laboratories Major Business
Table 37. Dr. Reddy's Laboratories Vinorelbine Product and Services
Table 38. Dr. Reddy's Laboratories Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 40. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Major Business
Table 41. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Product and Services
Table 42. Hangzhou Minsheng Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Nanjing Cuccess Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Nanjing Cuccess Pharmaceutical Co., Ltd Major Business
Table 45. Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Product and Services
Table 46. Nanjing Cuccess Pharmaceutical Co., Ltd Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Qilu Pharmaceutical (Hainan) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 48. Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
Table 49. Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Product and Services
Table 50. Qilu Pharmaceutical (Hainan) Co., Ltd. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Sinopharm A-Think Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 52. Sinopharm A-Think Pharmaceutical Co., Ltd. Major Business
Table 53. Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Product and Services
Table 54. Sinopharm A-Think Pharmaceutical Co., Ltd. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Beijing SL Pharm Basic Information, Manufacturing Base and Competitors
Table 56. Beijing SL Pharm Major Business
Table 57. Beijing SL Pharm Vinorelbine Product and Services
Table 58. Beijing SL Pharm Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Shenzhen Main Luck Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 60. Shenzhen Main Luck Pharmaceuticals Inc. Major Business
Table 61. Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Product and Services
Table 62. Shenzhen Main Luck Pharmaceuticals Inc. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Shanxi Powerdone Pharmaceutics Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. Shanxi Powerdone Pharmaceutics Co., Ltd. Major Business
Table 65. Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Product and Services
Table 66. Shanxi Powerdone Pharmaceutics Co., Ltd. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Luoxin Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 68. Luoxin Pharmaceutical Group Co., Ltd. Major Business
Table 69. Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Product and Services
Table 70. Luoxin Pharmaceutical Group Co., Ltd. Vinorelbine Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Global Vinorelbine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 72. Global Vinorelbine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 73. Market Position of Manufacturers in Vinorelbine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 74. Global Vinorelbine Production Capacity by Company, (MT): 2020 VS 2021
Table 75. Head Office and Vinorelbine Production Site of Key Manufacturer
Table 76. Vinorelbine New Entrant and Capacity Expansion Plans
Table 77. Vinorelbine Mergers & Acquisitions in the Past Five Years
Table 78. Global Vinorelbine Sales by Region (2017-2022) & (MT)
Table 79. Global Vinorelbine Sales by Region (2023-2028) & (MT)
Table 80. Global Vinorelbine Revenue by Region (2017-2022) & (USD Million)
Table 81. Global Vinorelbine Revenue by Region (2023-2028) & (USD Million)
Table 82. Global Vinorelbine Sales by Type (2017-2022) & (MT)
Table 83. Global Vinorelbine Sales by Type (2023-2028) & (MT)
Table 84. Global Vinorelbine Revenue by Type (2017-2022) & (USD Million)
Table 85. Global Vinorelbine Revenue by Type (2023-2028) & (USD Million)
Table 86. Global Vinorelbine Price by Type (2017-2022) & (USD/Kg)
Table 87. Global Vinorelbine Price by Type (2023-2028) & (USD/Kg)
Table 88. Global Vinorelbine Sales by Application (2017-2022) & (MT)
Table 89. Global Vinorelbine Sales by Application (2023-2028) & (MT)
Table 90. Global Vinorelbine Revenue by Application (2017-2022) & (USD Million)
Table 91. Global Vinorelbine Revenue by Application (2023-2028) & (USD Million)
Table 92. Global Vinorelbine Price by Application (2017-2022) & (USD/Kg)
Table 93. Global Vinorelbine Price by Application (2023-2028) & (USD/Kg)
Table 94. North America Vinorelbine Sales by Country (2017-2022) & (MT)
Table 95. North America Vinorelbine Sales by Country (2023-2028) & (MT)
Table 96. North America Vinorelbine Revenue by Country (2017-2022) & (USD Million)
Table 97. North America Vinorelbine Revenue by Country (2023-2028) & (USD Million)
Table 98. North America Vinorelbine Sales by Type (2017-2022) & (MT)
Table 99. North America Vinorelbine Sales by Type (2023-2028) & (MT)
Table 100. North America Vinorelbine Sales by Application (2017-2022) & (MT)
Table 101. North America Vinorelbine Sales by Application (2023-2028) & (MT)
Table 102. Europe Vinorelbine Sales by Country (2017-2022) & (MT)
Table 103. Europe Vinorelbine Sales by Country (2023-2028) & (MT)
Table 104. Europe Vinorelbine Revenue by Country (2017-2022) & (USD Million)
Table 105. Europe Vinorelbine Revenue by Country (2023-2028) & (USD Million)
Table 106. Europe Vinorelbine Sales by Type (2017-2022) & (MT)
Table 107. Europe Vinorelbine Sales by Type (2023-2028) & (MT)
Table 108. Europe Vinorelbine Sales by Application (2017-2022) & (MT)
Table 109. Europe Vinorelbine Sales by Application (2023-2028) & (MT)
Table 110. Asia-Pacific Vinorelbine Sales by Region (2017-2022) & (MT)
Table 111. Asia-Pacific Vinorelbine Sales by Region (2023-2028) & (MT)
Table 112. Asia-Pacific Vinorelbine Revenue by Region (2017-2022) & (USD Million)
Table 113. Asia-Pacific Vinorelbine Revenue by Region (2023-2028) & (USD Million)
Table 114. Asia-Pacific Vinorelbine Sales by Type (2017-2022) & (MT)
Table 115. Asia-Pacific Vinorelbine Sales by Type (2023-2028) & (MT)
Table 116. Asia-Pacific Vinorelbine Sales by Application (2017-2022) & (MT)
Table 117. Asia-Pacific Vinorelbine Sales by Application (2023-2028) & (MT)
Table 118. South America Vinorelbine Sales by Country (2017-2022) & (MT)
Table 119. South America Vinorelbine Sales by Country (2023-2028) & (MT)
Table 120. South America Vinorelbine Revenue by Country (2017-2022) & (USD Million)
Table 121. South America Vinorelbine Revenue by Country (2023-2028) & (USD Million)
Table 122. South America Vinorelbine Sales by Type (2017-2022) & (MT)
Table 123. South America Vinorelbine Sales by Type (2023-2028) & (MT)
Table 124. South America Vinorelbine Sales by Application (2017-2022) & (MT)
Table 125. South America Vinorelbine Sales by Application (2023-2028) & (MT)
Table 126. Middle East & Africa Vinorelbine Sales by Region (2017-2022) & (MT)
Table 127. Middle East & Africa Vinorelbine Sales by Region (2023-2028) & (MT)
Table 128. Middle East & Africa Vinorelbine Revenue by Region (2017-2022) & (USD Million)
Table 129. Middle East & Africa Vinorelbine Revenue by Region (2023-2028) & (USD Million)
Table 130. Middle East & Africa Vinorelbine Sales by Type (2017-2022) & (MT)
Table 131. Middle East & Africa Vinorelbine Sales by Type (2023-2028) & (MT)
Table 132. Middle East & Africa Vinorelbine Sales by Application (2017-2022) & (MT)
Table 133. Middle East & Africa Vinorelbine Sales by Application (2023-2028) & (MT)
Table 134. Vinorelbine Raw Material
Table 135. Key Manufacturers of Vinorelbine Raw Materials
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. Vinorelbine Typical Distributors
Table 139. Vinorelbine Typical Customers
List of Figures
Figure 1. Vinorelbine Picture
Figure 2. Global Vinorelbine Revenue Market Share by Type in 2021
Figure 3. Oral
Figure 4. Injection
Figure 5. Global Vinorelbine Revenue Market Share by Application in 2021
Figure 6. Breast Cancer
Figure 7. Non-small Cell Lung Cancer
Figure 8. Other
Figure 9. Global Vinorelbine Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 10. Global Vinorelbine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Vinorelbine Sales (2017-2028) & (MT)
Figure 12. Global Vinorelbine Price (2017-2028) & (USD/Kg)
Figure 13. Global Vinorelbine Production Capacity (2017-2028) & (MT)
Figure 14. Global Vinorelbine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Vinorelbine Market Drivers
Figure 16. Vinorelbine Market Restraints
Figure 17. Vinorelbine Market Trends
Figure 18. Global Vinorelbine Sales Market Share by Manufacturer in 2021
Figure 19. Global Vinorelbine Revenue Market Share by Manufacturer in 2021
Figure 20. Vinorelbine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Vinorelbine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Vinorelbine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Vinorelbine Sales Market Share by Region (2017-2028)
Figure 24. Global Vinorelbine Revenue Market Share by Region (2017-2028)
Figure 25. North America Vinorelbine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Vinorelbine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Vinorelbine Revenue (2017-2028) & (USD Million)
Figure 28. South America Vinorelbine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Vinorelbine Revenue (2017-2028) & (USD Million)
Figure 30. Global Vinorelbine Sales Market Share by Type (2017-2028)
Figure 31. Global Vinorelbine Revenue Market Share by Type (2017-2028)
Figure 32. Global Vinorelbine Price by Type (2017-2028) & (USD/Kg)
Figure 33. Global Vinorelbine Sales Market Share by Application (2017-2028)
Figure 34. Global Vinorelbine Revenue Market Share by Application (2017-2028)
Figure 35. Global Vinorelbine Price by Application (2017-2028) & (USD/Kg)
Figure 36. North America Vinorelbine Sales Market Share by Type (2017-2028)
Figure 37. North America Vinorelbine Sales Market Share by Application (2017-2028)
Figure 38. North America Vinorelbine Sales Market Share by Country (2017-2028)
Figure 39. North America Vinorelbine Revenue Market Share by Country (2017-2028)
Figure 40. United States Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Vinorelbine Sales Market Share by Type (2017-2028)
Figure 44. Europe Vinorelbine Sales Market Share by Application (2017-2028)
Figure 45. Europe Vinorelbine Sales Market Share by Country (2017-2028)
Figure 46. Europe Vinorelbine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Vinorelbine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Vinorelbine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Vinorelbine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Vinorelbine Revenue Market Share by Region (2017-2028)
Figure 56. China Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Vinorelbine Sales Market Share by Type (2017-2028)
Figure 63. South America Vinorelbine Sales Market Share by Application (2017-2028)
Figure 64. South America Vinorelbine Sales Market Share by Country (2017-2028)
Figure 65. South America Vinorelbine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Vinorelbine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Vinorelbine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Vinorelbine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Vinorelbine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Vinorelbine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Vinorelbine in 2021
Figure 77. Manufacturing Process Analysis of Vinorelbine
Figure 78. Vinorelbine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
